Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic features of liquid biopsies from patients with prostate cancer with and without ductal adenocarcinoma.

The journal of pathology. Clinical research - 1 May 2025

Zhu Qiyu, Wang Ting, Shi Yifu, Zhou Xiuya, Liu Dingbang, Chen Junru, Liu Haoyang, Zhao Fengnian, Xu Chenhao, Chen Yuntian, Liang Jiayu, Chen Ni, Shen Pengfei, Zeng Hao, Zhao Jinge

Abstract excerpt

Ductal adenocarcinoma of the prostate (DA) is relatively rare and highly co-existent with prostate adenocarcinoma (AC). This study aimed to investigate the distinctive genomic profiles of patients with DA compared to those without. Blood samples were obtained from 144 patients (36 with DA and 108 without DA) who were diagnosed from 2017 to 2023 at West China Hospital. We performed cell-free DNA sequencing to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ductal

Share to Genomics

Share to Hepatocyte Nuclear Factor 3-alpha

Share to Liquid Biopsy

Share to Prognosis

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 40172755
DOI: 10.1002/2056-4538.70026
PMCID: PMC11963801

Genes

AR
FOXA1
SPOP
TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic features of liquid biopsies from patients with prostate cancer with and without ductal adenocarcinoma.PMID 40172755Read ↗

Genomic analysis of aggressive ductal adenocarcinoma of the prostate.Semantic proximity Read ↗

Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene MutationsSemantic proximity Read ↗

Genomic Profiling of Prostate Cancer: An Updated ReviewSemantic proximity Read ↗

The Genomic and Molecular Pathology of Prostate Cancer: Clinical Implications for Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classificationSemantic proximity Read ↗

Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancerSemantic proximity Read ↗

Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype.Semantic proximity Read ↗

Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease ProgressionSemantic proximity Read ↗

Genetic profile of ductal adenocarcinoma of the prostate.Semantic proximity Read ↗

Unraveling the Complexity of Prostate Adenocarcinoma: Integrative Insights from Spatial Transcriptome and Single Cell AnalysisSemantic proximity Read ↗

Pan-urologic cancer genomic subtypes that transcend tissue of origin.Semantic proximity Read ↗

Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.